Gregory D. Kutz, Managing Director, Forensic Audits and Special Investigations, Governmental Accountability Office, Washington, DC

Kathy Hudson, Director, Genetics & Public Policy Center, John Hopkins University, Berman Bioethics Institute, Washington, DC

Rosalynn Gill-Garrison, Chief Science Officer, Sciona, Boulder, Colorado

Carol Reed, VP and Chief Medical Officer, Genaissance Pharmaceuticals, Newton, Massachusetts

Kristopher King, CEO, Suracell, Montclair, Jnew Jersey

Rama Rathnam, President, Genox, Baltimore, Maryland

Howard Coleman, CEO, Genelex Corporation, Seattle, Washington

Thomas Hamilton, Director, Survey and Certification Group, Centers for Medicare and Medicaid Services, US Department of Health and Human Services, Washington, DC

Steven M. Gutman, MD, Director, Office of in Vitro Diagnostic Devices, Food and Drug Administration, Washington, DC